MIRTAZAPINE

MIRTAZAPINE was reported 93073 times

MIRTAZAPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 184 0.1708
1 DELUSION OF GRANDEUR 72 0.1604
2 INTRUSIVE THOUGHTS 125 0.1061
3 COGWHEEL RIGIDITY 109 0.1038
4 ANTICHOLINERGIC SYNDROME 165 0.1035
5 ELECTRIC SHOCK 64 0.0747
6 GASTRIC PH DECREASED 76 0.0741
7 SEROTONIN SYNDROME 1360 0.0707
8 CONSCIOUSNESS FLUCTUATING 62 0.0594
9 SYSTEMIC INFECTION 93 0.0561
10 PRODUCT MONITORING ERROR 79 0.0547
11 BEZOAR 72 0.0522
12 DEREALISATION 109 0.0506
13 SOPOR 646 0.0487
14 H1N1 INFLUENZA 68 0.0484
15 POISONING DELIBERATE 458 0.0483
16 SLEEP PARALYSIS 70 0.0477
17 INTENTIONAL SELF-INJURY 948 0.0469
18 URINARY TRACT DISORDER 207 0.0459
19 SUSPECTED SUICIDE 210 0.0448
20 ACCIDENTAL DEATH 83 0.0446
21 NEUROLEPTIC MALIGNANT SYNDROME 529 0.0446
22 NONINFECTIVE GINGIVITIS 63 0.0435
23 MULTIPLE DRUG OVERDOSE INTENTIONAL 138 0.0429
24 HALLUCINATIONS, MIXED 180 0.0428
25 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 438 0.0426
26 COMA SCALE ABNORMAL 123 0.0424
27 HYPERKINESIA 89 0.0419
28 PSYCHOMOTOR RETARDATION 117 0.0416
29 DEPRESSIVE SYMPTOM 144 0.0408
30 MAJOR DEPRESSION 297 0.0406
31 WRONG PATIENT RECEIVED PRODUCT 118 0.0403
32 ILLUSION 66 0.0399
33 FEELING OF DESPAIR 183 0.0392
34 ANXIETY DISORDER 126 0.0377
35 AKATHISIA 514 0.0376
36 SEDATION COMPLICATION 96 0.0376
37 STOMA SITE ERYTHEMA 70 0.0374
38 BRADYKINESIA 218 0.0369
39 MUSCLE RIGIDITY 429 0.0358
40 POTENTIATING DRUG INTERACTION 120 0.0357
41 ELECTRIC SHOCK SENSATION 100 0.0357
42 CLEFT PALATE 69 0.0357
43 PARKINSONISM 340 0.0348
44 ON AND OFF PHENOMENON 192 0.0346
45 HAEMORRHAGIC STROKE 269 0.0344
46 DISSOCIATION 256 0.0334
47 HYPERREFLEXIA 116 0.0333
48 HYPOMANIA 122 0.0331
49 SLOW SPEECH 80 0.0329
50 RESTLESS LEGS SYNDROME 595 0.0327
51 SELF-INJURIOUS IDEATION 135 0.0321
52 STOMA SITE DISCHARGE 87 0.0318
53 SUICIDE ATTEMPT 1927 0.0317
54 INTENTIONAL OVERDOSE 2009 0.0313
55 MULTIPLE DRUG OVERDOSE 153 0.0308
56 ELECTROCARDIOGRAM QT PROLONGED 1108 0.0308
57 ACUTE PSYCHOSIS 76 0.0307
58 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253 0.0306
59 CATATONIA 161 0.0306
60 PERSONALITY DISORDER 80 0.0305
61 FREEZING PHENOMENON 113 0.0305
62 TACHYPHRENIA 105 0.0303
63 OSTEITIS 75 0.0297
64 PERSECUTORY DELUSION 74 0.0296
65 COMPLETED SUICIDE 2468 0.0296
66 MIOSIS 237 0.0295
67 GESTATIONAL DIABETES 140 0.0294
68 HOMICIDAL IDEATION 118 0.0291
69 BRADYPHRENIA 185 0.0283
70 SUICIDAL BEHAVIOUR 117 0.0281
71 STUPOR 90 0.0280
72 COMA 1331 0.0279
73 SEDATION 729 0.0278
74 VITAMIN B12 DECREASED 80 0.0277
75 HALLUCINATION, VISUAL 586 0.0277
76 ALTERED STATE OF CONSCIOUSNESS 600 0.0277
77 ALCOHOL POISONING 74 0.0276
78 SUICIDAL IDEATION 2495 0.0272
79 DELIRIUM 944 0.0272
80 FAILURE TO THRIVE 141 0.0271
81 HYPERPARATHYROIDISM SECONDARY 68 0.0271
82 DIABETIC NEUROPATHY 134 0.0270
83 LABYRINTHITIS 68 0.0269
84 MYOCLONUS 320 0.0268
85 HALLUCINATION, AUDITORY 426 0.0268
86 DIABETIC COMA 75 0.0268
87 DELUSION 414 0.0266
88 AFFECTIVE DISORDER 208 0.0264
89 URINARY HESITATION 63 0.0264
90 LOGORRHOEA 93 0.0264
91 HYPONATRAEMIA 1485 0.0263
92 HYPERACUSIS 98 0.0263
93 HYPERCAPNIA 78 0.0259
94 ALCOHOL USE 95 0.0257
95 PSYCHOMOTOR SKILLS IMPAIRED 67 0.0256
96 AGITATION 1861 0.0253
97 IMPULSIVE BEHAVIOUR 95 0.0253
98 ANTIPSYCHOTIC DRUG LEVEL INCREASED 71 0.0252
99 DEPRESSED LEVEL OF CONSCIOUSNESS 994 0.0251
100 MANIA 410 0.0249
101 POSTURE ABNORMAL 81 0.0249
102 CLONUS 68 0.0248
103 POISONING 312 0.0248
104 OCULAR DISCOMFORT 276 0.0246
105 PSYCHOTIC DISORDER 724 0.0245
106 RESTLESSNESS 894 0.0244
107 ELECTROENCEPHALOGRAM ABNORMAL 77 0.0244
108 BLOOD PHOSPHORUS DECREASED 88 0.0241
109 RESPIRATORY DEPRESSION 293 0.0239
110 BRADYPNOEA 64 0.0237
111 TOXICITY TO VARIOUS AGENTS 3985 0.0236
112 LOOSE TOOTH 76 0.0236
113 ANORGASMIA 64 0.0236
114 SUBSTANCE USE DISORDER 75 0.0235
115 RESPIRATORY ACIDOSIS 92 0.0234
116 NEPHROGENIC ANAEMIA 108 0.0233
117 ASPHYXIA 190 0.0233
118 SLEEP TERROR 97 0.0230
119 POLYDIPSIA 91 0.0230
120 AUTONOMIC NERVOUS SYSTEM IMBALANCE 67 0.0229
121 PRIAPISM 79 0.0229
122 DYSAESTHESIA 70 0.0228
123 MYDRIASIS 293 0.0228
124 DYSKINESIA 926 0.0228
125 DRUG ABUSE 1896 0.0228
126 COMMUNICATION DISORDER 87 0.0227
127 BEHAVIOUR DISORDER 120 0.0222
128 HYPERTONIA 126 0.0220
129 INCONTINENCE 232 0.0219
130 DRUG INTERACTION 3471 0.0219
131 DROOLING 151 0.0218
132 GENERALISED OEDEMA 266 0.0215
133 TEARFULNESS 92 0.0214
134 OBSESSIVE-COMPULSIVE DISORDER 171 0.0213
135 DISORIENTATION 839 0.0212
136 PARANOIA 365 0.0212
137 ALCOHOLISM 90 0.0210
138 NIGHTMARE 721 0.0208
139 PNEUMONIA ASPIRATION 519 0.0208
140 AGGRESSION 1038 0.0207
141 ANGER 701 0.0207
142 ELECTROCARDIOGRAM ABNORMAL 162 0.0206
143 SNORING 78 0.0206
144 TOXIC ENCEPHALOPATHY 104 0.0205
145 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 181 0.0205
146 POST-TRAUMATIC STRESS DISORDER 136 0.0203
147 HYPERNATRAEMIA 101 0.0202
148 SUBSTANCE ABUSE 164 0.0201
149 PANIC DISORDER 78 0.0201
150 HUMERUS FRACTURE 97 0.0201
151 EXTRAPYRAMIDAL DISORDER 494 0.0199
152 COORDINATION ABNORMAL 277 0.0198
153 NEUTROPHIL COUNT INCREASED 203 0.0198
154 URINARY RETENTION 660 0.0198
155 FAECALOMA 108 0.0197
156 SCHIZOPHRENIA 239 0.0196
157 HAEMATEMESIS 496 0.0195
158 SINUS TACHYCARDIA 277 0.0195
159 FEELING OF BODY TEMPERATURE CHANGE 114 0.0194
160 HEAD DISCOMFORT 342 0.0193
161 SOCIAL AVOIDANT BEHAVIOUR 111 0.0192
162 INCOHERENT 124 0.0191
163 PANIC REACTION 138 0.0191
164 BIPOLAR DISORDER 207 0.0190
165 SEXUAL DYSFUNCTION 221 0.0188
166 CONFUSIONAL STATE 3041 0.0188
167 HYPERVENTILATION 109 0.0188
168 SUDDEN CARDIAC DEATH 64 0.0188
169 DECUBITUS ULCER 152 0.0186
170 DYSARTHRIA 693 0.0184
171 THERAPEUTIC PRODUCT INEFFECTIVE 71 0.0183
172 ATELECTASIS 177 0.0183
173 DYSTONIA 355 0.0183
174 ORTHOSTATIC HYPOTENSION 318 0.0182
175 MUSCLE TWITCHING 418 0.0181
176 TACHYCARDIA 1587 0.0178
177 SOMNAMBULISM 117 0.0178
178 HYPERLIPIDAEMIA 213 0.0178
179 ARTERIOSCLEROSIS CORONARY ARTERY 118 0.0178
180 MALNUTRITION 198 0.0177
181 SENSORY LOSS 141 0.0175
182 TORSADE DE POINTES 137 0.0174
183 BUNDLE BRANCH BLOCK RIGHT 80 0.0174
184 PANIC ATTACK 633 0.0174
185 APATHY 253 0.0173
186 HALLUCINATION 1305 0.0173
187 CEREBRAL ATROPHY 69 0.0173
188 ATRIOVENTRICULAR BLOCK FIRST DEGREE 75 0.0173
189 HYPERPHAGIA 69 0.0173
190 DECREASED INTEREST 102 0.0173
191 ATAXIA 205 0.0173
192 WITHDRAWAL SYNDROME 721 0.0172
193 CACHEXIA 88 0.0171
194 HYPERTRIGLYCERIDAEMIA 100 0.0171
195 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 85 0.0170
196 HYPERAMMONAEMIA 85 0.0170
197 HYPOTHERMIA 172 0.0170
198 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 87 0.0170
199 HYPOVOLAEMIA 99 0.0169
200 RHABDOMYOLYSIS 703 0.0168
201 HYPERTHERMIA 128 0.0167
202 PULMONARY CONGESTION 218 0.0165
203 PSYCHOMOTOR HYPERACTIVITY 274 0.0165
204 CIRCULATORY COLLAPSE 280 0.0164
205 DYSPHORIA 82 0.0162
206 OBESITY 256 0.0161
207 THINKING ABNORMAL 298 0.0160
208 CARDIO-RESPIRATORY ARREST 668 0.0160
209 BLOOD LACTIC ACID INCREASED 84 0.0159
210 PERSONALITY CHANGE 148 0.0159
211 GLUCOSE TOLERANCE IMPAIRED 94 0.0159
212 SUDDEN DEATH 168 0.0159
213 UNRESPONSIVE TO STIMULI 408 0.0158
214 TYPE 2 DIABETES MELLITUS 531 0.0158
215 SOMNOLENCE 3163 0.0157
216 MENTAL STATUS CHANGES 436 0.0157
217 PRE-EXISTING CONDITION IMPROVED 98 0.0157
218 ASPIRATION 171 0.0156
219 SPINAL OSTEOARTHRITIS 137 0.0156
220 DRUG TOXICITY 211 0.0155
221 TYPE 1 DIABETES MELLITUS 93 0.0154
222 DEPRESSED MOOD 816 0.0154
223 PHOTOPHOBIA 288 0.0153
224 STATUS EPILEPTICUS 172 0.0152
225 DRUG USE DISORDER 128 0.0152
226 DEMENTIA 425 0.0152
227 SALIVARY HYPERSECRETION 152 0.0152
228 DRUG TOLERANCE 76 0.0150
229 FOOD CRAVING 79 0.0150
230 ANGIOPATHY 84 0.0150
231 SINUS BRADYCARDIA 144 0.0149
232 ABNORMAL DREAMS 411 0.0149
233 PRESYNCOPE 360 0.0148
234 ABNORMAL BEHAVIOUR 585 0.0148
235 DEPRESSION 3344 0.0147
236 PREMATURE LABOUR 83 0.0147
237 SLEEP APNOEA SYNDROME 280 0.0147
238 BLOOD SODIUM DECREASED 276 0.0146
239 PAROSMIA 110 0.0146
240 FEELING DRUNK 108 0.0145
241 PELVIC FRACTURE 113 0.0145
242 BLOOD CREATINE PHOSPHOKINASE INCREASED 416 0.0144
243 HYPOMAGNESAEMIA 201 0.0144
244 BRAIN OEDEMA 182 0.0144
245 TRISMUS 74 0.0143
246 TENSION 87 0.0143
247 BLOOD PROLACTIN INCREASED 67 0.0142
248 LEFT VENTRICULAR DYSFUNCTION 95 0.0142
249 HYPOPHAGIA 362 0.0141
250 CLOSTRIDIUM DIFFICILE COLITIS 150 0.0141
251 SCREAMING 90 0.0141
252 DISTURBANCE IN ATTENTION 761 0.0141
253 MENTAL IMPAIRMENT 342 0.0141
254 UROSEPSIS 130 0.0141
255 MENTAL DISORDER 613 0.0141
256 HYPOKALAEMIA 646 0.0140
257 HEPATIC STEATOSIS 260 0.0139
258 PSYCHIATRIC SYMPTOM 103 0.0139
259 TINNITUS 641 0.0139
260 HYPERSOMNIA 399 0.0139
261 COGNITIVE DISORDER 647 0.0138
262 INCREASED APPETITE 264 0.0138
263 SLEEP DISORDER 975 0.0138
264 BLOOD MAGNESIUM DECREASED 119 0.0138
265 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 75 0.0138
266 BRUXISM 74 0.0137
267 RESPIRATORY ARREST 377 0.0137
268 PYELONEPHRITIS 118 0.0136
269 HYPERPROLACTINAEMIA 88 0.0136
270 TREMOR 2245 0.0135
271 VENTRICULAR FIBRILLATION 150 0.0135
272 SMALL FOR DATES BABY 67 0.0135
273 AGRANULOCYTOSIS 250 0.0134
274 TARDIVE DYSKINESIA 379 0.0134
275 ANHEDONIA 353 0.0134
276 NYSTAGMUS 71 0.0134
277 ACUTE PULMONARY OEDEMA 74 0.0132
278 NEUTROPENIC SEPSIS 94 0.0131
279 ENCEPHALOPATHY 323 0.0131
280 FLANK PAIN 123 0.0131
281 MUSCLE DISORDER 106 0.0131
282 METABOLIC DISORDER 76 0.0131
283 LEUKOCYTOSIS 236 0.0130
284 SPEECH DISORDER 683 0.0130
285 LOSS OF LIBIDO 117 0.0130
286 DIPLOPIA 337 0.0130
287 HOSPICE CARE 128 0.0129
288 UPPER GASTROINTESTINAL HAEMORRHAGE 218 0.0129
289 AFFECT LABILITY 124 0.0129
290 ANXIETY 3651 0.0128
291 FALL 4248 0.0128
292 HYPOKINESIA 185 0.0127
293 GENERALISED TONIC-CLONIC SEIZURE 210 0.0127
294 ECONOMIC PROBLEM 190 0.0125
295 MOOD SWINGS 398 0.0125
296 BLOOD CALCIUM DECREASED 140 0.0124
297 EYE MOVEMENT DISORDER 85 0.0124
298 PANCREATITIS ACUTE 277 0.0123
299 EMPHYSEMA 124 0.0123
300 MATERNAL DRUGS AFFECTING FOETUS 94 0.0122
301 ANAL INCONTINENCE 110 0.0122
302 ABNORMAL WEIGHT GAIN 151 0.0122
303 END STAGE RENAL DISEASE 222 0.0122
304 HEPATITIS ACUTE 79 0.0121
305 APPETITE DISORDER 80 0.0121
306 OSTEOPENIA 182 0.0120
307 HEPATITIS CHOLESTATIC 72 0.0119
308 REFUSAL OF TREATMENT BY PATIENT 78 0.0119
309 CARDIOMEGALY 146 0.0119
310 WRONG PRODUCT ADMINISTERED 80 0.0118
311 GAMMA-GLUTAMYLTRANSFERASE INCREASED 262 0.0118
312 HYPOTONIA 118 0.0118
313 ASCITES 347 0.0118
314 GENERAL PHYSICAL HEALTH DETERIORATION 1365 0.0118
315 POOR QUALITY SLEEP 253 0.0117
316 BALANCE DISORDER 1014 0.0117
317 POLYURIA 96 0.0117
318 DRUG LEVEL INCREASED 194 0.0117
319 PHOTOPSIA 74 0.0117
320 EATING DISORDER 249 0.0117
321 HYPOXIA 411 0.0117
322 HEPATIC CYTOLYSIS 148 0.0116
323 SYNCOPE 1161 0.0116
324 GRAND MAL CONVULSION 107 0.0116
325 INSOMNIA 3077 0.0115
326 DIZZINESS POSTURAL 112 0.0115
327 DYSPHAGIA 1091 0.0115
328 BLOOD ALBUMIN DECREASED 91 0.0115
329 BLEPHAROSPASM 72 0.0114
330 FEAR 307 0.0114
331 PULMONARY OEDEMA 511 0.0114
332 ACUTE KIDNEY INJURY 1736 0.0113
333 IMPAIRED GASTRIC EMPTYING 154 0.0113
334 ACUTE RESPIRATORY FAILURE 217 0.0113
335 ACCIDENTAL OVERDOSE 412 0.0113
336 FEELING JITTERY 214 0.0112
337 EUPHORIC MOOD 115 0.0112
338 CYANOSIS 176 0.0112
339 BRAIN FOG 175 0.0112
340 EPILEPSY 341 0.0111
341 DIABETES MELLITUS 850 0.0111
342 HYPOAESTHESIA ORAL 168 0.0111
343 SKIN LACERATION 121 0.0111
344 OLIGURIA 69 0.0111
345 TOOTH FRACTURE 122 0.0111
346 IRON DEFICIENCY ANAEMIA 102 0.0110
347 LOSS OF CONSCIOUSNESS 1414 0.0110
348 DRUG SCREEN POSITIVE 87 0.0110
349 MENSTRUAL DISORDER 91 0.0110
350 HYPERHIDROSIS 1415 0.0110
351 BLOOD TRIGLYCERIDES INCREASED 194 0.0110
352 DIABETES MELLITUS INADEQUATE CONTROL 193 0.0109
353 GALACTORRHOEA 70 0.0109
354 TACHYPNOEA 148 0.0109
355 DECREASED APPETITE 2520 0.0108
356 HAEMATURIA 370 0.0108
357 MEDICATION ERROR 600 0.0108
358 DYSGRAPHIA 71 0.0108
359 EXERCISE TOLERANCE DECREASED 62 0.0108
360 RIB FRACTURE 221 0.0107
361 ACUTE RESPIRATORY DISTRESS SYNDROME 190 0.0107
362 BRADYCARDIA 569 0.0107
363 RENAL CYST 85 0.0107
364 LYMPHOCYTE COUNT DECREASED 189 0.0107
365 URINARY INCONTINENCE 315 0.0106
366 LYMPHOEDEMA 73 0.0105
367 NERVE INJURY 117 0.0105
368 TROPONIN INCREASED 80 0.0105
369 IRRITABILITY 626 0.0104
370 NIGHT SWEATS 335 0.0104
371 HAEMATOCRIT DECREASED 206 0.0104
372 CHRONIC KIDNEY DISEASE 789 0.0104
373 NOCTURIA 126 0.0104
374 VITAMIN D DEFICIENCY 101 0.0103
375 METABOLIC ACIDOSIS 331 0.0103
376 BEDRIDDEN 136 0.0103
377 HYPERGLYCAEMIA 377 0.0103
378 SEIZURE 1195 0.0103
379 LACTIC ACIDOSIS 335 0.0103
380 SENSORY DISTURBANCE 166 0.0103
381 APHASIA 312 0.0103
382 LIVER FUNCTION TEST ABNORMAL 300 0.0103
383 EXTRASYSTOLES 72 0.0103
384 HYPERKALAEMIA 360 0.0103
385 CARDIAC ARREST 847 0.0102
386 DRUG ABUSER 63 0.0102
387 ELECTROLYTE IMBALANCE 119 0.0102
388 MOTOR DYSFUNCTION 104 0.0102
389 LETHARGY 587 0.0102
390 SUBDURAL HAEMATOMA 146 0.0102
391 TRICUSPID VALVE INCOMPETENCE 81 0.0102
392 HEMIPARESIS 172 0.0101
393 PALLOR 276 0.0101
394 INITIAL INSOMNIA 104 0.0101
395 SUPRAVENTRICULAR TACHYCARDIA 97 0.0101
396 PARALYSIS 145 0.0101
397 HYPOCALCAEMIA 191 0.0101
398 HYPOTENSION 2024 0.0101
399 FORMICATION 70 0.0100
400 CHOLESTASIS 193 0.0100
401 POLYNEUROPATHY 120 0.0100
402 CONVULSION 571 0.0100
403 GASTROINTESTINAL INFECTION 89 0.0099
404 THIRST 177 0.0099
405 TRANSAMINASES INCREASED 220 0.0099
406 BLOOD ALKALINE PHOSPHATASE INCREASED 245 0.0099
407 AMNESIA 641 0.0098
408 ERECTILE DYSFUNCTION 252 0.0098
409 DRY MOUTH 796 0.0098
410 GLOMERULAR FILTRATION RATE DECREASED 120 0.0098
411 MOOD ALTERED 266 0.0097
412 HEPATOCELLULAR INJURY 138 0.0097
413 FEEDING DISORDER 197 0.0097
414 ATRIOVENTRICULAR BLOCK COMPLETE 65 0.0097
415 HIP FRACTURE 312 0.0097
416 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 504 0.0096
417 BODY TEMPERATURE DECREASED 95 0.0096
418 OVERDOSE 2079 0.0096
419 MICTURITION URGENCY 110 0.0096
420 CARDIAC FAILURE ACUTE 64 0.0096
421 RENAL TUBULAR NECROSIS 94 0.0096
422 BLOOD POTASSIUM DECREASED 288 0.0096
423 HIATUS HERNIA 124 0.0096
424 GASTRITIS 252 0.0096
425 LIVE BIRTH 80 0.0096
426 HYPERCHOLESTEROLAEMIA 92 0.0095
427 DIABETIC KETOACIDOSIS 228 0.0095
428 MUSCLE ATROPHY 120 0.0095
429 DENTAL CARIES 104 0.0094
430 QUALITY OF LIFE DECREASED 126 0.0094
431 DYSURIA 345 0.0094
432 COLD SWEAT 165 0.0094
433 RESPIRATORY FAILURE 679 0.0093
434 ORAL CANDIDIASIS 122 0.0093
435 BLINDNESS 377 0.0092
436 DEHYDRATION 1234 0.0092
437 ARTERIOSCLEROSIS 87 0.0092
438 CONTRAINDICATED PRODUCT ADMINISTERED 279 0.0092
439 JOINT DISLOCATION 97 0.0092
440 SHOCK HAEMORRHAGIC 74 0.0091
441 SPINAL COMPRESSION FRACTURE 75 0.0091
442 HEAD INJURY 287 0.0091
443 URINARY TRACT INFECTION 1545 0.0090
444 WEIGHT INCREASED 2026 0.0090
445 CONSTIPATION 1958 0.0090
446 LEUKOPENIA 446 0.0089
447 RESPIRATORY RATE INCREASED 79 0.0089
448 ACIDOSIS 68 0.0089
449 INTERNATIONAL NORMALISED RATIO INCREASED 253 0.0089
450 SEPSIS 989 0.0089
451 INTERVERTEBRAL DISC DEGENERATION 82 0.0089
452 SMALL INTESTINAL OBSTRUCTION 109 0.0088
453 OXYGEN SATURATION DECREASED 496 0.0088
454 WHITE BLOOD CELL COUNT INCREASED 338 0.0088
455 HYPOPHOSPHATAEMIA 65 0.0088
456 HAEMODYNAMIC INSTABILITY 67 0.0088
457 LOWER GASTROINTESTINAL HAEMORRHAGE 65 0.0088
458 BLOOD PRESSURE FLUCTUATION 211 0.0088
459 VENTRICULAR TACHYCARDIA 144 0.0087
460 SWOLLEN TONGUE 272 0.0087
461 BRAIN INJURY 87 0.0087
462 EYE PAIN 487 0.0086
463 BODY TEMPERATURE INCREASED 176 0.0086
464 IMMUNOSUPPRESSION 76 0.0086
465 FRACTURE 163 0.0086
466 PRODUCT PRESCRIBING ERROR 205 0.0086
467 DYSSTASIA 251 0.0086
468 CAESAREAN SECTION 100 0.0086
469 NEURALGIA 208 0.0085
470 OEDEMA PERIPHERAL 1033 0.0085
471 VENTRICULAR EXTRASYSTOLES 88 0.0085
472 GAIT DISTURBANCE 1619 0.0085
473 GASTROINTESTINAL PAIN 93 0.0084
474 ACUTE CORONARY SYNDROME 70 0.0084
475 ILEUS 105 0.0084
476 IMPAIRED DRIVING ABILITY 96 0.0084
477 DECREASED ACTIVITY 91 0.0084
478 MOBILITY DECREASED 606 0.0084
479 EMOTIONAL DISORDER 260 0.0084
480 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 405 0.0084
481 PANCREATITIS 442 0.0084
482 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 215 0.0083
483 FIBROMYALGIA 203 0.0083
484 NERVOUSNESS 434 0.0083
485 WEIGHT DECREASED 2305 0.0082
486 PANCYTOPENIA 461 0.0082
487 MUSCLE STRAIN 71 0.0082
488 GROIN PAIN 72 0.0082
489 RESPIRATORY DISTRESS 226 0.0082
490 HYPERAESTHESIA 67 0.0081
491 DYSPNOEA EXERTIONAL 307 0.0081
492 ASTHENIA 3063 0.0081
493 ALANINE AMINOTRANSFERASE INCREASED 500 0.0081
494 DEVICE RELATED INFECTION 125 0.0081
495 ATRIAL SEPTAL DEFECT 68 0.0081
496 PULMONARY HYPERTENSION 169 0.0081
497 PALPITATIONS 949 0.0081
498 INTERVERTEBRAL DISC PROTRUSION 177 0.0081
499 LIMB INJURY 219 0.0081
500 SUBARACHNOID HAEMORRHAGE 82 0.0080
501 HYPOGLYCAEMIA 390 0.0080
502 BLOOD CHOLESTEROL INCREASED 374 0.0080
503 MOVEMENT DISORDER 257 0.0080
504 PULMONARY MASS 119 0.0080
505 CRYING 290 0.0080
506 MUSCULOSKELETAL STIFFNESS 698 0.0080
507 HEART RATE IRREGULAR 180 0.0080
508 HAEMORRHOIDS 155 0.0079
509 CLOSTRIDIUM DIFFICILE INFECTION 173 0.0079
510 VERTIGO 479 0.0079
511 SLUGGISHNESS 80 0.0078
512 RED BLOOD CELL COUNT DECREASED 224 0.0078
513 ARRHYTHMIA 370 0.0078
514 HEART RATE INCREASED 773 0.0078
515 DRUG WITHDRAWAL SYNDROME 684 0.0078
516 PULMONARY EMBOLISM 738 0.0078
517 TOXIC SKIN ERUPTION 78 0.0077
518 MUSCLE SPASTICITY 95 0.0077
519 HAEMATOMA 200 0.0077
520 MELAENA 169 0.0077
521 HYPOTHYROIDISM 245 0.0077
522 BLOOD IRON DECREASED 91 0.0077
523 WOUND 214 0.0076
524 IMPAIRED QUALITY OF LIFE 110 0.0076
525 TUBULOINTERSTITIAL NEPHRITIS 143 0.0076
526 VISION BLURRED 1047 0.0076
527 CARDIOTOXICITY 68 0.0076
528 TREATMENT NONCOMPLIANCE 417 0.0076
529 CONDITION AGGRAVATED 2311 0.0076
530 MITRAL VALVE INCOMPETENCE 86 0.0076
531 OESOPHAGITIS 83 0.0076
532 SCAR 130 0.0076
533 INTESTINAL OBSTRUCTION 286 0.0076
534 C-REACTIVE PROTEIN INCREASED 276 0.0076
535 LUNG INFILTRATION 67 0.0076
536 CELLULITIS 381 0.0076
537 ABDOMINAL PAIN 1753 0.0075
538 HEPATOMEGALY 74 0.0075
539 SCIATICA 120 0.0075
540 CARDIAC MURMUR 65 0.0075
541 PERIPHERAL COLDNESS 103 0.0075
542 BLOOD PRESSURE SYSTOLIC INCREASED 146 0.0075
543 SPUTUM DISCOLOURED 71 0.0075
544 NEPHROPATHY TOXIC 84 0.0075
545 HUNGER 104 0.0075
546 RENAL FAILURE ACUTE 316 0.0074
547 NEUROTOXICITY 130 0.0074
548 FOETAL EXPOSURE DURING PREGNANCY 603 0.0074
549 MIDDLE INSOMNIA 138 0.0074
550 DIZZINESS 3670 0.0074
551 SHOCK 169 0.0073
552 ACTIVITIES OF DAILY LIVING IMPAIRED 145 0.0073
553 PLATELET COUNT INCREASED 95 0.0073
554 CHILLS 853 0.0073
555 RENAL PAIN 77 0.0073
556 BLOOD PRESSURE INCREASED 1110 0.0073
557 MEMORY IMPAIRMENT 997 0.0072
558 ASPARTATE AMINOTRANSFERASE INCREASED 385 0.0072
559 ROTATOR CUFF SYNDROME 93 0.0072
560 RENAL FAILURE 961 0.0072
561 DRUG-INDUCED LIVER INJURY 227 0.0072
562 HYPERTENSION 1532 0.0072
563 DRUG WITHDRAWAL SYNDROME NEONATAL 107 0.0072
564 OSTEOARTHRITIS 306 0.0072
565 PARAESTHESIA 1134 0.0072
566 URINE OUTPUT DECREASED 63 0.0072
567 PETECHIAE 75 0.0072
568 DRY THROAT 73 0.0072
569 MYALGIA 1220 0.0072
570 GASTROOESOPHAGEAL REFLUX DISEASE 577 0.0072
571 DERMATITIS ALLERGIC 90 0.0071
572 PHARYNGEAL SWELLING 70 0.0071
573 VOMITING 3361 0.0071
574 PRESCRIBED OVERDOSE 138 0.0071
575 LACERATION 67 0.0071
576 LIGAMENT SPRAIN 70 0.0071
577 TEMPERATURE INTOLERANCE 73 0.0071
578 AGEUSIA 176 0.0070
579 THERAPY NON-RESPONDER 317 0.0070
580 GASTRIC ULCER 134 0.0070
581 ANGINA PECTORIS 202 0.0070
582 MUSCULAR WEAKNESS 801 0.0070
583 BLOOD POTASSIUM INCREASED 114 0.0070
584 EAR DISCOMFORT 72 0.0070
585 MUSCULOSKELETAL CHEST PAIN 108 0.0070
586 GASTROINTESTINAL HAEMORRHAGE 583 0.0070
587 MUSCLE TIGHTNESS 113 0.0070
588 HEPATIC CIRRHOSIS 131 0.0070
589 CARDIOGENIC SHOCK 100 0.0070
590 TRANSIENT ISCHAEMIC ATTACK 235 0.0070
591 RENAL IMPAIRMENT 585 0.0070
592 DEEP VEIN THROMBOSIS 451 0.0069
593 PNEUMONIA 2246 0.0069
594 PRODUCT ADMINISTRATION ERROR 140 0.0069
595 GASTROENTERITIS 101 0.0069
596 ANAEMIA 1315 0.0069
597 MUSCLE SPASMS 1264 0.0069
598 ACUTE HEPATIC FAILURE 94 0.0069
599 BLOOD UREA INCREASED 115 0.0069
600 HEPATIC ENCEPHALOPATHY 64 0.0069
601 TOOTHACHE 124 0.0068
602 WOUND INFECTION 75 0.0068
603 HYPERTENSIVE CRISIS 76 0.0068
604 NERVOUS SYSTEM DISORDER 213 0.0068
605 HYPERCALCAEMIA 84 0.0068
606 HEPATITIS C 82 0.0068
607 POOR VENOUS ACCESS 70 0.0068
608 NEUROPATHY PERIPHERAL 643 0.0068
609 SPINAL DISORDER 64 0.0068
610 BLOOD CREATININE INCREASED 441 0.0067
611 FAECES DISCOLOURED 146 0.0067
612 MYOCARDITIS 77 0.0067
613 LYMPHOPENIA 95 0.0067
614 OEDEMA 363 0.0067
615 PREMATURE BABY 201 0.0067
616 TOOTH INFECTION 88 0.0067
617 ANOREXIA 86 0.0067
618 PHOTOSENSITIVITY REACTION 110 0.0067
619 RECTAL HAEMORRHAGE 286 0.0067
620 FEELING COLD 185 0.0066
621 CHROMATURIA 150 0.0066
622 CHOLECYSTITIS 79 0.0066
623 GAIT INABILITY 221 0.0066
624 ORAL PAIN 148 0.0066
625 WRIST FRACTURE 79 0.0066
626 SWELLING FACE 429 0.0066
627 CONTUSION 634 0.0066
628 PLEURAL EFFUSION 399 0.0066
629 IRRITABLE BOWEL SYNDROME 140 0.0065
630 BLOOD PRESSURE DECREASED 433 0.0065
631 SARS-COV-2 TEST POSITIVE 86 0.0065
632 WEIGHT FLUCTUATION 68 0.0065
633 POLLAKIURIA 271 0.0065
634 SPLENOMEGALY 76 0.0065
635 HYPOAESTHESIA 971 0.0065
636 DYSPEPSIA 638 0.0065
637 NAUSEA 5125 0.0065
638 DIARRHOEA 4173 0.0065
639 CANDIDA INFECTION 109 0.0064
640 MUSCULOSKELETAL PAIN 338 0.0064
641 HAEMOGLOBIN DECREASED 662 0.0064
642 CYST 80 0.0064
643 OSTEOPOROSIS 265 0.0064
644 FATIGUE 5007 0.0064
645 SPINAL PAIN 75 0.0064
646 DEVICE OCCLUSION 90 0.0064
647 JAUNDICE 172 0.0064
648 HYPERBILIRUBINAEMIA 66 0.0064
649 DYSPNOEA 3601 0.0064
650 SEASONAL ALLERGY 90 0.0064
651 LOWER RESPIRATORY TRACT INFECTION 289 0.0063
652 METASTASES TO BONE 104 0.0063
653 EOSINOPHILIA 111 0.0063
654 INTENTIONAL PRODUCT MISUSE 554 0.0063
655 ABDOMINAL DISTENSION 660 0.0063
656 MALAISE 2770 0.0063
657 ATRIAL FIBRILLATION 614 0.0063
658 STEVENS-JOHNSON SYNDROME 140 0.0063
659 OBSTRUCTIVE AIRWAYS DISORDER 70 0.0063
660 CARDIOMYOPATHY 93 0.0063
661 INFUSION SITE PAIN 81 0.0063
662 CARPAL TUNNEL SYNDROME 88 0.0063
663 CHEST PAIN 1162 0.0063
664 PRODUCTIVE COUGH 297 0.0062
665 LIP SWELLING 207 0.0062
666 BREAST PAIN 66 0.0062
667 PERICARDIAL EFFUSION 143 0.0062
668 PYREXIA 2137 0.0062
669 FEELING ABNORMAL 1474 0.0061
670 MYOCARDIAL ISCHAEMIA 70 0.0061
671 PULMONARY THROMBOSIS 67 0.0061
672 LIMB DISCOMFORT 189 0.0061
673 BONE MARROW FAILURE 124 0.0061
674 CYSTITIS 194 0.0061
675 PREMATURE DELIVERY 97 0.0061
676 EPISTAXIS 453 0.0060
677 FACE OEDEMA 102 0.0060
678 REBOUND EFFECT 68 0.0060
679 COLITIS 228 0.0060
680 PRODUCT PRESCRIBING ISSUE 131 0.0060
681 SKIN ULCER 155 0.0060
682 THROMBOCYTOPENIA 668 0.0060
683 PHARYNGITIS 74 0.0060
684 TOOTH EXTRACTION 74 0.0059
685 CORONARY ARTERY DISEASE 180 0.0059
686 COAGULOPATHY 99 0.0059
687 HEPATITIS 152 0.0059
688 ADRENAL INSUFFICIENCY 72 0.0059
689 DRUG PRESCRIBING ERROR 114 0.0059
690 BACK PAIN 1378 0.0059
691 INTENTIONAL DRUG MISUSE 124 0.0059
692 ABDOMINAL PAIN UPPER 1220 0.0059
693 HAEMORRHAGE INTRACRANIAL 88 0.0059
694 HEPATOTOXICITY 131 0.0059
695 RED BLOOD CELL SEDIMENTATION RATE INCREASED 65 0.0059
696 DRUG INTOLERANCE 567 0.0059
697 TASTE DISORDER 119 0.0059
698 BACK DISORDER 95 0.0058
699 PRODUCT USE IN UNAPPROVED INDICATION 1447 0.0058
700 BRONCHOSPASM 83 0.0058
701 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 319 0.0058
702 ROAD TRAFFIC ACCIDENT 243 0.0058
703 METASTASES TO LUNG 67 0.0058
704 ACUTE MYOCARDIAL INFARCTION 171 0.0058
705 CHOLELITHIASIS 190 0.0058
706 RETCHING 123 0.0058
707 FOOT FRACTURE 109 0.0057
708 MOUTH ULCERATION 121 0.0057
709 PNEUMOTHORAX 91 0.0057
710 SEPTIC SHOCK 249 0.0057
711 VISUAL IMPAIRMENT 706 0.0057
712 ACCIDENT 68 0.0057
713 RESPIRATORY DISORDER 170 0.0057
714 JOINT STIFFNESS 149 0.0057
715 JOINT INJURY 121 0.0057
716 KIDNEY INFECTION 111 0.0057
717 PHARYNGEAL OEDEMA 87 0.0056
718 HAEMATOCHEZIA 312 0.0056
719 BACTERAEMIA 67 0.0056
720 BLOOD PRESSURE ABNORMAL 112 0.0056
721 ANKLE FRACTURE 87 0.0056
722 PAIN IN JAW 159 0.0056
723 HEART RATE DECREASED 197 0.0056
724 DIVERTICULITIS 155 0.0056
725 SPINAL FRACTURE 112 0.0056
726 RESPIRATORY TRACT INFECTION 145 0.0056
727 IMPAIRED WORK ABILITY 119 0.0056
728 BRONCHITIS 412 0.0056
729 LYMPHADENOPATHY 197 0.0056
730 BLOOD LACTATE DEHYDROGENASE INCREASED 88 0.0055
731 CARDIAC FAILURE 445 0.0055
732 NODULE 72 0.0055
733 NEUTROPHIL COUNT DECREASED 224 0.0055
734 LUNG INFECTION 85 0.0055
735 EJECTION FRACTION DECREASED 85 0.0055
736 PNEUMONITIS 148 0.0054
737 PRESCRIBED UNDERDOSE 108 0.0054
738 HAEMOPTYSIS 151 0.0054
739 NECK PAIN 302 0.0054
740 CEREBRAL HAEMORRHAGE 193 0.0054
741 ISCHAEMIC STROKE 96 0.0054
742 UPPER LIMB FRACTURE 107 0.0054
743 BLOOD BILIRUBIN INCREASED 145 0.0054
744 BONE PAIN 314 0.0054
745 RENAL INJURY 159 0.0053
746 BURNING SENSATION 375 0.0053
747 LUNG DISORDER 262 0.0053
748 ULCER 85 0.0053
749 WHEEZING 316 0.0053
750 ORAL DISCOMFORT 74 0.0053
751 ARTHRALGIA 2210 0.0053
752 CENTRAL NERVOUS SYSTEM LESION 73 0.0053
753 MUCOSAL INFLAMMATION 139 0.0053
754 STAPHYLOCOCCAL INFECTION 175 0.0053
755 METASTASES TO LIVER 93 0.0053
756 PERIPHERAL SWELLING 815 0.0053
757 COUGH 1481 0.0053
758 CHOKING 103 0.0053
759 CHEST DISCOMFORT 540 0.0053
760 TOXIC EPIDERMAL NECROLYSIS 80 0.0053
761 PLATELET COUNT DECREASED 561 0.0053
762 OROPHARYNGEAL PAIN 487 0.0053
763 MULTIPLE ORGAN DYSFUNCTION SYNDROME 149 0.0053
764 ADVERSE DRUG REACTION 471 0.0052
765 NEUTROPENIA 713 0.0052
766 HEPATIC ENZYME INCREASED 357 0.0052
767 MUSCULOSKELETAL DISCOMFORT 90 0.0052
768 LIVER FUNCTION TEST INCREASED 112 0.0052
769 BLOOD URINE PRESENT 99 0.0052
770 MULTI-ORGAN FAILURE 90 0.0052
771 BURSITIS 63 0.0052
772 MIGRAINE 494 0.0052
773 LOCALISED INFECTION 125 0.0052
774 HEADACHE 3239 0.0052
775 PAIN IN EXTREMITY 1514 0.0051
776 MATERNAL EXPOSURE DURING PREGNANCY 455 0.0051
777 SKIN DISCOLOURATION 234 0.0051
778 NEPHROLITHIASIS 233 0.0051
779 PARAESTHESIA ORAL 73 0.0051
780 FEBRILE NEUTROPENIA 333 0.0050
781 HEPATIC FUNCTION ABNORMAL 186 0.0050
782 EMOTIONAL DISTRESS 603 0.0050
783 ABDOMINAL DISCOMFORT 834 0.0050
784 BLOOD COUNT ABNORMAL 75 0.0049
785 RASH MACULO-PAPULAR 110 0.0049
786 BONE DISORDER 90 0.0049
787 ABASIA 122 0.0049
788 CARDIAC FAILURE CONGESTIVE 395 0.0049
789 DRY EYE 245 0.0049
790 EXPOSURE DURING PREGNANCY 304 0.0049
791 LIVER INJURY 120 0.0049
792 EAR PAIN 95 0.0049
793 PAIN 2977 0.0048
794 WHITE BLOOD CELL COUNT DECREASED 519 0.0048
795 DYSPHONIA 280 0.0048
796 TOOTH LOSS 99 0.0048
797 GASTROENTERITIS VIRAL 86 0.0048
798 GINGIVAL BLEEDING 65 0.0048
799 DISABILITY 94 0.0047
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 338 0.0047
801 HOSPITALISATION 730 0.0047
802 INFLUENZA LIKE ILLNESS 391 0.0047
803 PULMONARY FIBROSIS 91 0.0047
804 INFECTION 682 0.0047
805 POST PROCEDURAL COMPLICATION 90 0.0047
806 ANGIOEDEMA 207 0.0047
807 OFF LABEL USE 4081 0.0047
808 LOCAL SWELLING 81 0.0046
809 OSTEOMYELITIS 84 0.0046
810 LACRIMATION INCREASED 140 0.0046
811 DRUG ERUPTION 82 0.0046
812 MUSCULOSKELETAL DISORDER 88 0.0046
813 INJURY 323 0.0046
814 GLAUCOMA 88 0.0046
815 PRODUCT AVAILABILITY ISSUE 104 0.0046
816 OSTEONECROSIS OF JAW 113 0.0046
817 UPPER RESPIRATORY TRACT INFECTION 210 0.0045
818 IMPAIRED HEALING 149 0.0045
819 HOT FLUSH 342 0.0045
820 GALLBLADDER DISORDER 81 0.0045
821 LIVER DISORDER 201 0.0045
822 SKIN DISORDER 151 0.0045
823 DISEASE PROGRESSION 535 0.0045
824 UNEVALUABLE EVENT 342 0.0045
825 INFLUENZA 504 0.0045
826 ABDOMINAL PAIN LOWER 114 0.0045
827 PLASMA CELL MYELOMA 175 0.0045
828 HEPATIC FAILURE 135 0.0045
829 VIRAL INFECTION 149 0.0045
830 DRUG RESISTANCE 115 0.0045
831 RENAL DISORDER 208 0.0045
832 DRUG ADMINISTRATION ERROR 137 0.0045
833 ARTHRITIS 351 0.0045
834 RASH GENERALISED 115 0.0044
835 BLOOD TEST ABNORMAL 62 0.0044
836 ILLNESS 454 0.0044
837 HERNIA 85 0.0044
838 INTENTIONAL PRODUCT USE ISSUE 385 0.0044
839 CARDIOVASCULAR DISORDER 111 0.0044
840 VISUAL ACUITY REDUCED 145 0.0044
841 TOOTH DISORDER 97 0.0044
842 THERAPY PARTIAL RESPONDER 68 0.0044
843 FLUID RETENTION 221 0.0043
844 CEREBRAL INFARCTION 105 0.0043
845 FEMUR FRACTURE 133 0.0043
846 FREQUENT BOWEL MOVEMENTS 116 0.0043
847 GOUT 77 0.0043
848 EAR INFECTION 114 0.0043
849 ABSCESS 68 0.0043
850 STOMATITIS 257 0.0042
851 BACTERIAL INFECTION 79 0.0042
852 DRUG EXPOSURE DURING PREGNANCY 144 0.0042
853 GASTROINTESTINAL DISORDER 378 0.0042
854 DISCOMFORT 257 0.0042
855 COVID-19 735 0.0042
856 CEREBROVASCULAR ACCIDENT 709 0.0042
857 BONE DENSITY DECREASED 131 0.0042
858 FEELING HOT 256 0.0042
859 THERAPEUTIC RESPONSE UNEXPECTED 187 0.0042
860 CATARACT 247 0.0041
861 FLATULENCE 235 0.0041
862 THROAT IRRITATION 185 0.0041
863 THROMBOSIS 331 0.0041
864 DEATH 3523 0.0041
865 MULTIPLE SCLEROSIS 195 0.0041
866 PRURITUS GENERALISED 88 0.0041
867 DYSGEUSIA 302 0.0041
868 GASTRIC DISORDER 139 0.0040
869 FULL BLOOD COUNT DECREASED 81 0.0040
870 DEAFNESS 105 0.0040
871 PROTEINURIA 76 0.0040
872 SWELLING 373 0.0040
873 PRODUCT SUBSTITUTION ISSUE 229 0.0040
874 MULTIPLE FRACTURES 65 0.0040
875 UNDERDOSE 288 0.0039
876 JOINT SWELLING 473 0.0039
877 PROCEDURAL PAIN 108 0.0039
878 ASTHMA 438 0.0039
879 THROAT TIGHTNESS 104 0.0038
880 THERAPY CESSATION 197 0.0038
881 INTENTIONAL DOSE OMISSION 109 0.0038
882 HAEMORRHAGE 399 0.0038
883 RASH MACULAR 133 0.0038
884 LOWER LIMB FRACTURE 73 0.0038
885 CARDIAC DISORDER 352 0.0038
886 SKIN LESION 103 0.0038
887 DRUG INEFFECTIVE 4903 0.0037
888 INFLAMMATION 192 0.0037
889 GLOSSODYNIA 83 0.0037
890 HERPES ZOSTER 213 0.0037
891 PHARMACEUTICAL PRODUCT COMPLAINT 96 0.0037
892 BLISTER 204 0.0036
893 MALIGNANT NEOPLASM PROGRESSION 371 0.0036
894 ILL-DEFINED DISORDER 220 0.0036
895 GYNAECOMASTIA 112 0.0036
896 PRURITUS 1375 0.0036
897 EYE SWELLING 133 0.0036
898 DRUG DEPENDENCE 572 0.0036
899 ARTHROPATHY 197 0.0035
900 SINUS DISORDER 70 0.0035
901 PERITONITIS 73 0.0035
902 RASH PRURITIC 191 0.0035
903 PELVIC PAIN 64 0.0035
904 SINUSITIS 361 0.0035
905 ABORTION SPONTANEOUS 141 0.0035
906 NASOPHARYNGITIS 638 0.0035
907 NEOPLASM PROGRESSION 120 0.0034
908 CONJUNCTIVITIS 64 0.0034
909 RASH 1497 0.0034
910 MULTIPLE SCLEROSIS RELAPSE 233 0.0034
911 COLITIS ULCERATIVE 151 0.0034
912 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 608 0.0034
913 THERAPY INTERRUPTED 241 0.0034
914 WRONG TECHNIQUE IN DRUG USAGE PROCESS 122 0.0034
915 LABORATORY TEST ABNORMAL 99 0.0034
916 PRODUCT DOSE OMISSION ISSUE 981 0.0033
917 DRUG EFFECT DECREASED 179 0.0033
918 HYPERSENSITIVITY 614 0.0033
919 NASAL CONGESTION 194 0.0033
920 PRODUCT DOSE OMISSION IN ERROR 93 0.0033
921 PRODUCT PHYSICAL ISSUE 66 0.0033
922 TREATMENT FAILURE 271 0.0033
923 SURGERY 191 0.0033
924 ERUCTATION 63 0.0033
925 ALOPECIA 637 0.0032
926 MYOCARDIAL INFARCTION 565 0.0032
927 ORAL HERPES 63 0.0032
928 SNEEZING 72 0.0032
929 RHINORRHOEA 207 0.0032
930 PRODUCT USE ISSUE 600 0.0032
931 FLUSHING 323 0.0032
932 THERAPEUTIC RESPONSE SHORTENED 105 0.0032
933 DISEASE RECURRENCE 150 0.0032
934 EYE DISORDER 103 0.0031
935 EYE PRURITUS 105 0.0031
936 INTERSTITIAL LUNG DISEASE 149 0.0031
937 DEVICE DISLOCATION 133 0.0031
938 PRODUCT DOSE OMISSION 198 0.0030
939 INFUSION RELATED REACTION 201 0.0030
940 ANAPHYLACTIC REACTION 166 0.0030
941 ADVERSE EVENT 273 0.0030
942 PAIN OF SKIN 79 0.0029
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 73 0.0029
944 HYPOACUSIS 124 0.0029
945 RASH ERYTHEMATOUS 137 0.0029
946 DRUG EFFECT INCOMPLETE 104 0.0029
947 BLOOD GLUCOSE INCREASED 536 0.0028
948 OSTEONECROSIS 93 0.0028
949 ECZEMA 146 0.0028
950 LUNG NEOPLASM MALIGNANT 112 0.0027
951 INCORRECT DOSE ADMINISTERED 619 0.0027
952 THERAPEUTIC PRODUCT EFFECT DECREASED 121 0.0027
953 SKIN BURNING SENSATION 192 0.0027
954 NEEDLE ISSUE 77 0.0026
955 BLOOD GLUCOSE DECREASED 127 0.0026
956 THERAPEUTIC RESPONSE DECREASED 160 0.0026
957 NEOPLASM MALIGNANT 173 0.0026
958 ERYTHEMA 527 0.0026
959 FUNGAL INFECTION 84 0.0025
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 175 0.0025
961 SKIN EXFOLIATION 206 0.0024
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 492 0.0024
963 URTICARIA 404 0.0024
964 OCULAR HYPERAEMIA 114 0.0024
965 DEVICE ISSUE 215 0.0024
966 DRUG DOSE OMISSION 391 0.0024
967 EYE IRRITATION 127 0.0022
968 DRY SKIN 293 0.0022
969 PSORIATIC ARTHROPATHY 89 0.0022
970 RHEUMATOID ARTHRITIS 246 0.0022
971 PSORIASIS 262 0.0020
972 INJECTION SITE MASS 73 0.0020
973 INJECTION SITE REACTION 129 0.0019
974 PRODUCT QUALITY ISSUE 249 0.0018
975 SYSTEMIC LUPUS ERYTHEMATOSUS 64 0.0018
976 EXTRA DOSE ADMINISTERED 65 0.0016
977 VAGINAL HAEMORRHAGE 69 0.0016
978 INJECTION SITE SWELLING 110 0.0014
979 DEVICE LEAKAGE 62 0.0014
980 DEPENDENCE 71 0.0013
981 INJECTION SITE PAIN 394 0.0013
982 INJECTION SITE HAEMORRHAGE 100 0.0013
983 INJECTION SITE BRUISING 96 0.0012
984 INJECTION SITE ERYTHEMA 146 0.0012
985 DERMATITIS ATOPIC 62 0.0012
986 BREAST CANCER 109 0.0012
987 DEVICE MALFUNCTION 80 0.0011
988 ACNE 85 0.0011
989 NO ADVERSE EVENT 187 0.0010
990 PROSTATE CANCER 71 0.0009
991 ACCIDENTAL EXPOSURE TO PRODUCT 85 0.0008
992 PRODUCT STORAGE ERROR 70 0.0008